Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence
figureposted on 13.04.2021, 16:23 by Adis journals on behalf of, Jacob Liseno, Brittney Lager, Catherine Miller, Sai L. Shankar, Jason P. Mendoza, James B. Lewin
Article full text
The above summary slide and infographic represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.